Adipocytokines and VLDL metabolism - Independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?

被引:95
作者
Ng, TWK
Watts, GF
Farvid, MS
Chan, DC
Hugh, P
Barrett, R
机构
[1] Univ Western Australia, Western Australian Inst Med Res, Sch Med & Pharmacol, Perth, WA 6009, Australia
[2] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Tehran, Iran
关键词
D O I
10.2337/diabetes.54.3.795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the relationship of plasma adipocytokine concentrations with VLDL apolipoprotein B (apoB)-100 kinetics in men. Plasma adiponectin, leptin, resistin, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) concentrations were measured using enzyme immunoassays and insulin resistance by homeostasis model assessment (HOMA) score in 41 men with BMI of 22-35 kg/m(2). VLDL apoB kinetics were determined using an intravenous infusion of 1-[C-13]leucine, gas chromatography-mass spectrometry, and compartmental modeling. Visceral and subcutaneous adipose tissue mass (ATM) were determined using magnetic resonance imaging, and total ATM was measured by bioelectrical impedance. In univariate regression, plasma adiponectin and leptin concentrations were inversely and directly associated, respectively, with plasma triglyceride; HOMA score; and visceral, subcutaneous, and total ATMs. Conversely, adiponectin and leptin were directly and inversely correlated, respectively, with VLDL apoB catabolism and HDL cholesterol concentration (P < 0.05). Resistin, IL-6, and TNF-alpha were not significantly associated with any of these variables. In multivariate regression, adiponectin was the most significant predictor of plasma VLDL apoB concentration (P = 0.001) and, together with total or subcutaneous ATM, was an independent predictor of VLDL apoB catabolism (P < 0.001); HOMA score was the most significant predictor of VLDL apoB hepatic secretion (P < 0.05). Leptin was not an independent predictor of VLDL apoB kinetics. In conclusion, plasma VLDL apoB kinetics may be differentially controlled by adiponectin and insulin resistance, with adiponectin regulating catabolism and insulin resistance regulating hepatic secretion in men. Total body fat may also independently determine the rate of VLDL catabolism, but leptin, resistin, IL-6, and TNF-alpha do not have a significant effect in regulating apoB kinetics.
引用
收藏
页码:795 / 802
页数:8
相关论文
共 42 条
[1]  
ABATE N, 1994, J LIPID RES, V35, P1490
[2]   Adiponectin relationship with lipid metabolism is independent of body fat mass:: Evidence from both cross-sectional and intervention studies [J].
Baratta, R ;
Amato, S ;
Degano, C ;
Farina, MG ;
Patanè, G ;
Vigneri, R ;
Frittitta, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2665-2671
[3]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[4]  
Blair SN, 1984, Behavioral health: A handbook o f health enhancement and disease prevention, P424
[5]   Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans [J].
Bruun, JM ;
Lihn, AS ;
Verdich, C ;
Pedersen, SB ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E527-E533
[6]   Adipose tissue compartments and insulin resistance in overweight-obese Caucasian men [J].
Chan, DC ;
Watts, GF ;
Sussekov, AV ;
Barrett, PHR ;
Yang, ZJ ;
Hua, JM ;
Song, ST .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 63 (02) :77-85
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations - Distinct metabolic effects of two fat compartments [J].
Cnop, M ;
Landchild, MJ ;
Vidal, J ;
Havel, PJ ;
Knowles, NG ;
Carr, DR ;
Wang, F ;
Hall, RL ;
Boyko, EJ ;
Retzlaff, BM ;
Walden, CE ;
Knopp, RH ;
Kahn, SE .
DIABETES, 2002, 51 (04) :1005-1015
[9]   Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex [J].
Cnop, M ;
Havel, PJ ;
Utzschneider, KM ;
Carr, DB ;
Sinha, MK ;
Boyko, EJ ;
Retzlaff, BM ;
Knopp, RH ;
Brunzell, JD ;
Kahn, SE .
DIABETOLOGIA, 2003, 46 (04) :459-469
[10]   A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity [J].
Combs, TP ;
Pajvani, UB ;
Berg, AH ;
Lin, Y ;
Jelicks, LA ;
Laplante, M ;
Nawrocki, AR ;
Rajala, MW ;
Parlow, AF ;
Cheeseboro, L ;
Ding, YY ;
Russell, RG ;
Lindemann, D ;
Hartley, A ;
Baker, GRC ;
Obici, S ;
Deshaies, Y ;
Ludgate, M ;
Rossetti, L ;
Scherer, PE .
ENDOCRINOLOGY, 2004, 145 (01) :367-383